However, a cohort study reported that melioidosis patients with a preadmission diagnosis of diabetes treated with glibenclamide had decreased levels of TNF-α, IL-18-R1, and IL-8 and lower in-hospital mortality compared to patients without diabetes [12]. This evidence concerns the gene TNF and diabetes mellitus.